Tag: adults

Posted on

In-Home Asthma Treatment Improves Adults’ Control – Medscape


KPLU News for Seattle and the Northwest

In-Home Asthma Treatment Improves Adults' Control
Medscape
Low-income adults with uncontrolled asthma had improved control and quality of life when they received five home visits per year by community health workers, according to study results published online November 24 in JAMA Internal Medicine.
Home Visits As Helpful As Medicine For King County Asthma PatientsKPLU News for Seattle and the Northwest
Home Visits Can Improve Asthma Control for Low-income AdultsHCPLive

all 5 news articles »

View full post on asthma – Google News

Posted on

What leads to weight loss success in adults with asthma? – EurekAlert (press release)

What leads to weight loss success in adults with asthma?
EurekAlert (press release)
Among overweight and obese adults who had asthma and participated in weight loss programs, more severe asthma, male sex, and improvements in eating behaviors were all linked with better success at losing weight. The finding that individuals with more …

and more »

View full post on asthma – Google News

Posted on

Combining COPD Therapies Aids Older Adults with Comorbid Asthma – Pharmacy Times


Lung Disease News

Combining COPD Therapies Aids Older Adults with Comorbid Asthma
Pharmacy Times
Unlike previous trials, this study allowed COPD patients with comorbid asthma to participate. This comorbidity is common, as most statistics report that up to one-third of COPD patients also have asthma. Ultimately, those with both COPD and asthma …
Better Outcomes For COPD Patients Related to LABAs and ICSsLung Disease News

all 2 news articles »

View full post on asthma – Google News

Posted on

A Non-inferiority Study to Evaluate Efficacy, Safety and Tolerability of NEUMOTEROL® 400 and SYMBICORT® Forte in Adults With Asthma

Condition:   Asthma
Interventions:   Drug: NEUMOTEROL 400 (BFF 400/12 mcg) single capsule inhaler;   Drug: SYMBICORT forte (BFF 320/9mcg) TURBUHALER inhaler;   Drug: NEUMOTEX 400 (Budesonide 400 mcg);   Drug: Salbutamol 100 mcg pMDI
Sponsors:   GlaxoSmithKline;   Laboratorios Phoenix
Not yet recruiting – verified September 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days

Posted on

Serial Lung Function Measurements in Healthy and Mild Asthmatic Adults After Oral Inhalation of Ethanolic Solutions Containing Two Concentrations of the Excipient Butylated Hydroxytoluene (BHT) Administered With the Respimat® B (RMT-B)

Condition:   Asthma
Interventions:   Drug: BHT 0.1%;   Drug: BHT 0.5%;   Drug: Placebo for RMT-B;   Drug: Placebo for HFA-MDI
Sponsor:   Boehringer Ingelheim
Completed – verified August 2014

View full post on ClinicalTrials.gov: asthma | received in the last 14 days